Nautilus Biotechnology, Inc. - FORM S-1/A - EX-23.1 - EXHIBIT 23.1 - July 29, 2020

Attached files

file filename
EX-10.1 - EXHIBIT 10.1 - Nautilus Biotechnology, Inc.nt10013610x3_ex10-1.htm
EX-99.3 - EXHIBIT 99.3 - Nautilus Biotechnology, Inc.nt10013610x3_ex99-3.htm
EX-99.2 - EXHIBIT 99.2 - Nautilus Biotechnology, Inc.nt10013610x3_ex99-2.htm
EX-10.8 - EXHIBIT 10.8 - Nautilus Biotechnology, Inc.nt10013610x3_ex10-8.htm
EX-10.7 - EXHIBIT 10.7 - Nautilus Biotechnology, Inc.nt10013610x3_ex10-7.htm
EX-10.6 - EXHIBIT 10.6 - Nautilus Biotechnology, Inc.nt10013610x3_ex10-6.htm
EX-10.5 - EXHIBIT 10.5 - Nautilus Biotechnology, Inc.nt10013610x3_ex10-5.htm
EX-10.4 - EXHIBIT 10.4 - Nautilus Biotechnology, Inc.nt10013610x3_ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - Nautilus Biotechnology, Inc.nt10013610x3_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - Nautilus Biotechnology, Inc.nt10013610x3_ex10-2.htm
EX-5.1 - EXHIBIT 5.1 - Nautilus Biotechnology, Inc.nt10013610x3_ex5-1.htm
EX-4.1 - EXHIBIT 4.1 - Nautilus Biotechnology, Inc.nt10013610x3_ex4-1.htm
EX-3.2 - EXHIBIT 3.2 - Nautilus Biotechnology, Inc.nt10013610x3_ex3-2.htm
EX-3.1 - EXHIBIT 3.1 - Nautilus Biotechnology, Inc.nt10013610x3_ex3-1.htm
EX-1.1 - EXHIBIT 1.1 - Nautilus Biotechnology, Inc.nt10013610x3_ex1-1.htm
S-1/A - S-1/A - Nautilus Biotechnology, Inc.nt10013610x3_s1a.htm
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We hereby consent to the use in this Registration Statement on Amendment No. 1 to Form S-1, of our report dated July 29, 2020, relating to the balance sheet of ARYA Sciences Acquisition Corp III as of April 2, 2020, and the related statements of operations, changes in shareholder’s equity and cash flows for the period from March 27, 2020 (inception) through April 2, 2020 and to the reference to our Firm under the caption “Experts” in the Prospectus.
 
/s/ WithumSmith+Brown, PC
 
 
 
New York, New York
 
July 29, 2020
  

Nautilus Biotechnology, Inc. Reports